Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer

Head and Neck

Volumn 32, Issue 4, 2010, Pages 513-528

  Frowen, Jacqui ^a   Cotton, Susan ^b   Corry, June ^b,c   Perry, Alison ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Chemotherapy; Dysphagia; Head and neck cancer; Radiotherapy; Swallowing

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; TIRAPAZAMINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLUOROSCOPY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX TUMOR; INTENSITY MODULATED RADIATION THERAPY; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OROPHARYNX TUMOR; OUTCOME ASSESSMENT; PHARYNX; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ASPIRATION; RADIATION FIELD; RURAL AREA; SQUAMOUS CELL CARCINOMA; SWALLOWING; TUMOR CLASSIFICATION; TUMOR VOLUME; VIDEORECORDING;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; DEGLUTITION; DEGLUTITION DISORDERS; DEMOGRAPHY; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM STAGING; PROBABILITY; PROSPECTIVE STUDIES; RADIATION INJURIES; RESPIRATORY ASPIRATION; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VIDEO RECORDING;

EID: 77949387745     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21218     Document Type: Article

References (44)

1. Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction - preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003;57:1219-1230.
2. Rosenthal D, Lewin J, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 2006;24:2636-2643.
3. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 2004;22:19-22.
4. Eisbruch A. Dysphagia and aspiration following chemoirradiation of head and neck cancer: major obstacles to intensification of therapy. Ann Oncol 2004;15:363-364.
5. Frowen JJ, Perry AR. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck 2006;28:932-944.
6. World Health Organization (WHO). International classification of functioning, disability and health. Geneva: WHO; 2001.
7. Logemann JA. Manual for the videofluorographic study of swallowing. 2nd ed. Austin, TX: Pro-Ed; 1993.
8. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003;25:432-437.
9. Rischin D, Peters L, Fisher R, et al. Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 2005;23:79-87.
10. Corry J, Rischin D, Peters L. The changing demography and treatment of nasopharyngeal carcinoma in Melbourne from 1985-2000. Cancer Rev Asia Pac 2003;1:65-75.
11. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:1-12.
12. Kotz T, Costello R, Li Y, Posner MR. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 2004;26:365-372.
13. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996;106:1157-1166.
14. Frowen J, Cotton S, Perry A. The stability, reliability, and validity of videofluoroscopy measures for patients with head and neck cancer. Dysphagia 2008;23:348-363.
15. Rosenbek JC, Robbins J, Roecker EB, Coyle JL, Wood JL. A penetration - aspiration scale. Dysphagia 1996;11:93-98.
16. Perry A, Skeat J. AusTOMs for speech pathology. Melbourne: La Trobe University; 2004.
17. Perry A, Morris M, Unsworth C, et al. Therapy outcome measures for allied health practitioners in Australia: the AusTOMs. Int J Qual Health Care 2004;16:285-291.
18. Tabachnick BG, Fidell LS. Using multivariate statistics. 4th ed. Boston, MA: Allyn and Bacon; 2001.
19. Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 2nd ed. Upper Saddle River, NJ: Prentice Hall Health; 2000.
20. Perry AR, Shaw MA, Cotton S. An evaluation of functional outcomes (speech, swallowing) in patients attending speech pathology after head and neck cancer treatment(s): results and analysis at 12 months postintervention. J Laryngol Otol 2003;117:368-381.
21. Logemann J, Pauloski B, Rademaker A, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 2008;30:148-158.
22. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-3589.
23. Caudell JJ, Schaner PE, Meredith RF, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2008;73:410-415.
24. Jong K, Smith D, Yu X, O'Connell D, Goldstein D, Armstrong B. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2005;180:618-622.
25. Australian Institute of Health and Welfare (AIHW). Rural, regional and remote health: indicators of health status and determinants of health (Rural Health Series no. 9. cat. no. PHE 97). Canberra: AIHW; 2008.
26. Deleyiannis FW-B, Thomas DB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 1996;88:542-549.
27. Langerman A, MacCracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM. Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2007;133:1289-1295.
28. Pauloski BR, Rademaker AW, Logemann JA, et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 2000;22:474-482.
29. Stenson KM, MacCracken E, List M, et al. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg 2000;126:371-377.
30. Kotz T, Abraham S, Beitler JJ, Wadler S, Smith RV. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 1999;125:410-413.
31. Logemann JA, Rademaker AW, Pauloski BR, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 2006;28:64-73.
32. Moore GJ, Parsons JT, Mendenhall WM. Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue. Int J Radiat Oncol Biol Phys 1996;36:351-354.
33. Shiley SG, Hargunani CA, Skoner JM, Holland JM, Wax MK. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 2006;134:455-459.
34. Hutcheson KA, Barringer DA, Rosenthal DI, May AH, Roberts DB, Lewin JS. Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 2008;134:178-183.
35. Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74-82.
36. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-1439.
37. Ng MK, Porceddu SV, Corry J, et al. Parotid-sparing radiotherapy: does it really reduce xerostomia? Clin Oncol 2005;17:610-617.
38. Lee NY, de Arruda FF, Puri DR, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;66:966-974.
39. Mittal BB, Kepka A, Mahadevan A, et al. Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers. Int J Cancer (Radiat Oncol Invest) 2001;96 (Suppl.):61-70.
40. Jensen K, Overgaard M, Grau C. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol 2007;85:90-97.
41. Feng F, Kim H, Lynden T, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose - effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007;68:1289-1298.
42. Caglar H, Tishler R, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:1110-1118.
43. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose - effect relationship. Radiother Oncol 2007;85:64-73.
44. Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007;68:750-757.